CRNX

Crinetics Pharmaceuticals, Inc.

CRNX · CIK 1658247 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$8M
20182025
Net Income−$465M
20182025
Operating CF−$378M
20182025
Free Cash Flow−$384M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.0B$0.0B—$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue$0.0B———————
Gross Profit————————
R&D Expense$0.3B$0.2B$0.2B$0.1B$0.1B$0.1B$0.0B$0.0B
SG&A Expense$0.2B———————
Operating Income$-0.5B$-0.3B$-0.2B$-0.2B$-0.1B$-0.1B$-0.1B$-0.0B
Net Income$-0.5B$-0.3B$-0.2B$-0.2B$-0.1B$-0.1B$-0.0B$-0.0B
EPS (Basic)$-4.95$-3.69$-3.69$-3.15————
EPS (Diluted)$-4.95$-3.69$-3.69$-3.15————

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.1B$1.4B$0.6B$0.4B$0.4B$0.2B$0.1B$0.2B
Current Assets$1.0B$1.4B$0.6B$0.3B$0.3B$0.2B$0.1B$0.2B
Cash & Equivalents$0.1B$0.3B$0.1B$0.0B$0.2B$0.1B$0.0B$0.0B
Total Liabilities$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$1.0B$1.3B$0.5B$0.3B$0.3B$0.2B$0.1B$0.2B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$-0.4B$-0.2B$-0.2B$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
Investing Cash Flow$0.2B$-0.6B$-0.2B$-0.2B$-0.1B$0.0B$0.0B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$1.0B$0.4B$0.1B$0.3B$0.1B$0.0B$0.2B
← Companies